Consensus Botanix Pharmaceuticals Limited

Equities

BOT

AU000000BOT2

Delayed Australian S.E. Other stock markets 06:14:58 26/06/2024 am IST			5-day change	1st Jan Change
0.355 ^AUD	-2.74%		-1.39%	+86.84%

21/06	Botanix Pharmaceuticals to Raise AU$70 Million via Institutional Placement	MT
20/06	Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication	MT

Evolution of the average Target Price on Botanix Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

48ecad2fac737d3c436b55566655d.PGI2gqO6NcPldvjV3ePa532BNIRx2ECf45BXueMtEXk.BRMb1eWJbbCsOZGS6IS7iyrnYLwU7w6ygvdj3It_ZgsOMw_pzoJ8rKAEsQ~3ba359a224d141da92a11721e9e13bfa

Analyst Recommendations on Botanix Pharmaceuticals Limited

Evans & Partners Starts Botanix Pharmaceuticals at Speculative Buy With AU$0.55 Price Target	21/05	MT
Euroz Hartleys Adjusts Botanix Pharmaceutical’s Price Target to AU$0.33 From AU$0.30, Keeps at Speculative Buy	13/05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.365 AUD

Average target price

0.55 AUD

Spread / Average Target

+50.68%

High Price Target

0.55 AUD

Spread / Highest target

+50.68%

Low Price Target

0.55 AUD

Spread / Lowest Target

+50.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Botanix Pharmaceuticals Limited

Evans & Partners
Euroz Hartleys

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar